Welcome to LookChem.com Sign In|Join Free
  • or
4-phenyl-1,2-dihydropyrazol-3-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

54934-30-4

Post Buying Request

54934-30-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

54934-30-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 54934-30-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,9,3 and 4 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 54934-30:
(7*5)+(6*4)+(5*9)+(4*3)+(3*4)+(2*3)+(1*0)=134
134 % 10 = 4
So 54934-30-4 is a valid CAS Registry Number.

54934-30-4Relevant academic research and scientific papers

β-Enamino esters in heterocyclic synthesis: Synthesis of pyrazolone and pyridinone derivatives

Salaheldin, Abdellatif Mohamed,Al-Sheikh, Mariam Abdullah

experimental part, p. 4359 - 4368 (2010/10/01)

An efficient and convenient synthesis of pyrrolidinones and pyridinones utilizing enamino esters as starting material has been described. The structures of the compounds obtained were confirmed by spectral and elemental analyses.

Synthesis and biological evaluation of novel pyrazoles and indazoles as activators of the nitric oxide receptor, soluble guanylate cyclase

Selwood,Brummell,Budworth,Burtin,Campbell,Chana,Charles,Fernandez,Glen,Goggin,Hobbs,Kling,Liu,Madge,Meillerais,Powell,Reynolds,Spacey,Stables,Tatlock,Wheeler,Wishart,Woo

, p. 78 - 93 (2007/10/03)

Database searching and compound screening identified 1-benzyl-3-(3-dimethylaminopropyloxy)-indazole (benzydamine, 3) as a potent activator of the nitric oxide receptor, soluble guanylate cyclase. A comprehensive structure-activity relationship study surrounding 3 clearly showed that the indazole C-3 dimethylaminopropyloxy substituent was critical for enzyme activity. However replacement of the indazole ring of 3 by appropriately substituted pyrazoles maintained enzyme activity. Compounds were evaluated for inhibition of platelet aggregation and showed a general lipophilicity requirement. Aryl-substituted pyrazoles 32, 34, and 43 demonstrated potent activation of soluble guanylate cyclase and potent inhibition of platelet aggregation. Pharmacokinetic studies in rats showed that compound 32 exhibits modest oral bioavailability (12%) Furthermore 32 has an excellent selectivity profile notably showing no significant inhibition of phosphodiesterases or nitric oxide synthases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 54934-30-4